Blockchain technology can help reducing energy inequality and inefficiency and empower consumers to buy and sell energy from other consumers directly. Energy companies can leverage blockchain to impact capital expenditure, security, operating costs, and risk management. In the energy industry, blockchain applications are growing increasingly common. The blockchain ledger is being used to reduce transaction costs, pinpoint origins of energy, and increase the efficiency of exchanges.
President Biden’s health secretary, Xavier Becerra, and his top medical adviser for the coronavirus, Dr. Anthony S. Fauci said Thursday that they intended to begin offering low and middle-income nations access to the technology developed by government scientists that might be used to prevent or treat Covid-19. They did not specify which technologies might be included, but hinted that the policy could eventually apply to the Moderna vaccine if the Biden administration won a patent dispute with the company.
US Food and Drug Administration has approved its first product, Carvykti (ciltacabtagene autoleucel; cilta-cel), for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) who have received four or more prior lines of therapy. The label gives the drug, formerly known as cilta-cel, a level playing field against Bristol and bluebird bio spinout 2seventy bio’s rival BCMA-targeted CAR-T drug Abecma, which arrived a year ago as a fifth-line treatment.
A draft of the European Union Data Act would require a smart contract kill switch that could have a profound effect on the use, and even usefulness, of commercial blockchain technology. Smart contracts are self-executing agreements that, once created, are effectively unchangeable and unstoppable. Specifically, Article 30 of the EU’s proposed Data Act says that smart contracts must have “a mechanism exists to terminate the continued execution of transactions: the smart contract shall include internal functions which can reset or instruct the contract to stop or interrupt the operation to avoid future (accidental) executions.”
According to market research firm the IMARC group, the global biometrics market reached a $27.97 billion valuation in 2021, and is expected to reach nearly $75 billion by 2027. Central to that gargantuan monetary figure are the eyeballs, heartbeats, and physical movements of people across the world, and—increasingly—employees who are clocking into work with their fingerprints or opening company devices with scans of their faces. Liz Brown, an associate professor of law and taxation at Bentley University, told HR Brew that she believes the increasing reliance on these tools in the workplace could be a cause of concern for employees “because companies’ use of this data is not transparent.”